Description

Tardiferon (iron (II)) tablets with prolonged release 80 mg. №30

Ingredients

Each tablet contains 80 mg of iron (II) in a prolonged-release formulation.

Dosage

The recommended dosage is one tablet daily, or as directed by a healthcare professional.

Indications

Tardiferon tablets are indicated for the treatment of iron deficiency anemia. They provide a slow and steady release of iron, ensuring optimal absorption and effectiveness.

Contraindications

Do not use Tardiferon tablets if you have a known hypersensitivity to any of the ingredients. Consult a healthcare provider before starting any new medication.

Directions

Swallow the tablet whole with a glass of water, preferably with food to minimize gastrointestinal side effects. Do not crush or chew the tablet.

Scientific Evidence

Iron deficiency anemia is a common condition worldwide, especially among women of childbearing age and individuals with poor dietary intake. Tardiferon tablets, with their prolonged-release formulation, have shown promising results in improving hemoglobin levels and iron stores in clinical studies.

One study published in the Journal of Hematology & Transfusion Medicine demonstrated that prolonged-release iron formulations like Tardiferon are well-tolerated and effective in treating iron deficiency anemia, with a lower incidence of gastrointestinal side effects compared to immediate-release iron supplements.

Additional Information

It is important to note that iron supplements should be taken under medical supervision, as excessive iron intake can lead to toxicity. If you experience any adverse effects while taking Tardiferon tablets, discontinue use and consult a healthcare professional.

For optimal results, it is recommended to follow a balanced diet rich in iron-containing foods while taking Tardiferon tablets. Regular monitoring of iron levels and hemoglobin is essential to assess the response to treatment.